Skip to main content

Johnson & Johnson

SEC CIK
0000200406
Latest filing
Aug 6, 2026

Holdings in Q4 2024

Holdings as of Dec 31, 2024, filed Feb 13, 2025. Long positions only; changes compare share counts with Q3 2024.

Institution overview
Positions
20
0 vs. Q3 2024
Portfolio value
$386.1M
−$41.2M (−9.6%) vs. Q3 2024
Filed
Feb 13, 2025
SEC
Holdings of Johnson & Johnson in Q4 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
PTGXProtagonist Therapeutics, IncCOM2,449,183$94.5M24.5%00.0%UnchangedHistory
CVRXCVRx, Inc.COM4,103,430$52.0M13.5%00.0%UnchangedHistory
RAPPRapport Therapeutics, Inc.COM2,498,051$44.3M11.5%00.0%UnchangedHistory
MGTXMeiraGTx Holdings plcCOM6,641,064$40.4M10.5%00.0%UnchangedHistory
CTNMContineum Therapeutics, Inc.CL A1,979,173$29.0M7.5%00.0%UnchangedHistory
PRCTPROCEPT BioRobotics CorpCOM357,939$28.8M7.5%00.0%UnchangedHistory
LEGNLegend Biotech CorpSPONSORED ADS814,586$26.5M6.9%00.0%UnchangedHistory
NMRANeumora Therapeutics, Inc.COM1,849,445$19.6M5.1%00.0%UnchangedHistory
XNCRXencor IncCOM748,062$17.2M4.5%00.0%UnchangedHistory
NBTXNanobiotix S.A.SPONSORED ADS5,623,816$16.1M4.2%00.0%UnchangedHistory
FATEFate Therapeutics IncCOM3,379,064$5.58M1.4%00.0%UnchangedHistory
ARWRArrowhead Pharmaceuticals, Inc.COM247,598$4.65M1.2%00.0%UnchangedHistory
RLYBRallybio CorpCOM3,636,363$3.49M0.9%00.0%UnchangedHistory
VORVor Biopharma Inc.COM1,074,658$1.19M0.3%00.0%UnchangedHistory
NNOXNano-X Imaging Ltd.ORD SHS158,852$1.14M0.3%00.0%UnchangedHistory
LABStandard Biotools Inc.COM311,967$545.9K0.1%00.0%UnchangedHistory
LYELLyell Immunopharma, Inc.COM823,317$526.9K0.1%+823,317NewHistory
ACETAdicet Bio, Inc.COM364,472$350.6K0.1%00.0%UnchangedHistory
HLSQTessera Defense & Homeland Security Inc.COM96,866$70.7K<0.1%−95,455−49.6%ReducedHistory
SENSSenseonics Holdings, Inc.COM54,621$28.6K<0.1%00.0%UnchangedHistory

Sold out since Q3 2024 (1)

Positions held at the end of Q3 2024 that are gone from this filing.

Positions of Johnson & Johnson sold out since Q3 2024
SecurityClassShares in Q3 2024Value in Q3 2024% of portfolio in Q3 2024History
CLSDClearside Biomedical, Inc.COM82,481$104.8K<0.1%History